Detected ·
Delix Therapeutics
$85M—
Delix Therapeutics is set to raise $85M in a Series C round led by Johnson & Johnson at a $190M pre-money valuation. Delix develops neuroplastogens — non-hallucinogenic drugs related to psychedelics.
- Website
- —
- —
- Amount
- $85 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-19 08:05:42 UTC
- Signal ID
- fbe03aa4-5185-48fb-88a7-f515ee870cc2
As the API returns it
{
"id": "fbe03aa4-5185-48fb-88a7-f515ee870cc2",
"created_at": "2026-08-19T08:05:42.098100Z",
"company_name": "Delix Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 85000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Delix Therapeutics is set to raise $85M in a Series C round led by Johnson & Johnson at a $190M pre-money valuation. Delix develops neuroplastogens — non-hallucinogenic drugs related to psychedelics.*"
}